Cited in:


This article has been cited by:

  1. 1
    Bram Estes, Yueh-Rong Hsu, Lei-Ting Tam, Jackie Sheng, Jennitte Stevens, Raj Haldankar, Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system, Biotechnology Progress, 2015, 31, 1
  2. 2
    Stevan Shaw, Tim Bourne, Chris Meier, Bruce Carrington, Rich Gelinas, Alistair Henry, Andrew Popplewell, Ralph Adams, Terry Baker, Steve Rapecki, Diane Marshall, Adrian Moore, Helen Neale, Alastair Lawson, Discovery and characterization of olokizumab, mAbs, 2014, 6, 3, 773


  3. 3
    Leon P. Pybus, Greg Dean, Nathan R. West, Andrew Smith, Olalekan Daramola, Ray Field, Stephen J. Wilkinson, David C. James, Model-directed engineering of “difficult-to-express” monoclonal antibody production by Chinese hamster ovary cells, Biotechnology and Bioengineering, 2014, 111, 2
  4. 4
    Daisuke Nishimiya, Proteins improving recombinant antibody production in mammalian cells, Applied Microbiology and Biotechnology, 2014, 98, 3, 1031


  5. 5
    Katharine Cain, Shirley Peters, Hanna Hailu, Bernie Sweeney, Paul Stephens, James Heads, Kaushik Sarkar, Andy Ventom, Catherine Page, Alan Dickson, A CHO cell line engineered to express XBP1 and ERO1-Lα has increased levels of transient protein expression, Biotechnology Progress, 2013, 29, 3